2012
DOI: 10.1007/s00408-011-9369-1
|View full text |Cite
|
Sign up to set email alerts
|

Endobronchial Valves in the Management of Broncho-Pleural and Alveolo-Pleural Fistulae

Abstract: Pneumothorax from bronchopleural or alveolo-pleural fistulae can be complicated by prolonged air leak (AL). This can occur in a variety of clinical settings. Examples include structural lung disease, such as bronchiectasis, and cavitary lung disorders. Prolonged AL is associated with prolonged hospital stay, atelectasis, pneumonia, and thromboembolic disease. Endobronchial valves (EBVs) have been recently introduced to manage such situations. The global experience in this novel therapeutic modality is still ev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 26 publications
0
23
0
1
Order By: Relevance
“…Their efficacy for management of postoperative air leak was later defined [1,9,11,12]. Other case reports have defined additional clinical scenarios in which EBVs were effectively used for elimination of airflow to specific regions of the lung [11,14,[16][17][18][19][20].…”
Section: Commentmentioning
confidence: 96%
“…Their efficacy for management of postoperative air leak was later defined [1,9,11,12]. Other case reports have defined additional clinical scenarios in which EBVs were effectively used for elimination of airflow to specific regions of the lung [11,14,[16][17][18][19][20].…”
Section: Commentmentioning
confidence: 96%
“…15,16 However, valves are also increasingly utilized in patients with persistent air leaks. 17,18 In our institution, placement of intrabronchial valves for persistent air leaks is approved under the institutional review board protocol (HSM#11-00015). Informed consent was obtained from our patient before the procedure.…”
Section: Discussionmentioning
confidence: 99%
“…It is usually treated with a drug combination for a period of 12 months [4,5]. In case of MAC lung disease with broncho-pleural or alveolar-pleural fistulas, endobronchial valves insertion can be attempted by experienced pulmonologists [6]. In advanced non-tuberculous mycobacterial pleuro-pulmonary disease, surgical interventions such as segmentectomy, lobectomy, pneumonectomy, or pleural decortication might be required with varying degree of morbidity and mortality [7,8].…”
Section: Discussionmentioning
confidence: 99%